Home Topics Categories Pharma & healthcare

Pharma & healthcare

Latest
Most Read

Filter by

Non-prescription, OTC products (587)

Healthcare services, providers (253)

DTC, prescription products (239)

Pharma & healthcare (general) (169)

Promotions to the medical profession (106)

Contraceptives, family planning (80)

Search in

Case Studies (100)

Articles (61)

Research Papers (56)

News (10)

Opinion (0)

Data (2)

Rankings (10)

Show only

Recommended

(7)

Videos

(31)

Date Range

All
Last year
Last three years
Last five years
Set date range

From

Search within

Search Results Language

Category

Brand

Location

Source

239 results found

Reset Filters

Search in

Case Studies (100)

Articles (61)

Research Papers (56)

News (10)

Opinion (0)

Data (2)

Rankings (10)

Show only

Recommended

(7)

Videos

(31)

Date Range

All
Last year
Last three years
Last five years
Set date range

From

Search within

template

Search Results Language

Industry Sector

template

Brand

template

Location

template

Source

template

239 results found

Sort By

Superimposed text size and contrast effects in DTC TV advertising: Bigger is better, high contrast not so much

Research Paper • Ryan S. Paquin, Amie C. O’Donoghue, Bridget J. Kelly, Kevin R. Betts, Mihaela Johnson, Christine N. Davis, Alyssa Jordan, and Peyton Williams, Journal of Advertising Research, Vol. 61, No. 2, 2021, pp. 178-191

Direct-to-consumer prescription-drug television advertisements often contain superimposed text (supers) to convey information about the advertised product.

AstraZeneca: Neb adventures

Case Study • WARC Awards for Effectiveness, Shortlisted, Customer Experience, 2021

Pharmaceutical company, AstraZeneca, combated low child asthma treatment completion rates with a child-centred approach in UAE.

Why pharmaceutical advertising doesn’t connect emotionally with its target

Article • Mike Cassell, WARC Exclusive, Spotlight US, May 2021

Looks at the reasons why much pharma advertising doesn’t make an emotional connection and what to do about it.

How behavioural science can help the medicine go down

Article • Crawford Hollingworth, Liz Barker, WARC Exclusive, Spotlight US, May 2021

Explores how behavioural science can improve health outcomes, in this article, focusing on defaults.

Pharma’s forever home: The move toward purpose-driven branded houses

Article • Carl Turner and Kameron Block, WARC Exclusive, Spotlight US, May 2021

Examines the rise of pharmaceutical and biotechnology companies as purpose-driven corporate brands.

Life, liberty and the pursuit of healthiness: How the American belief in competition underpins the US healthcare marketplace

Article • Brad Davidson PhD, WARC Exclusive, Spotlight US, May 2021

Provides insight into the US healthcare system and why a belief in the necessity of competition explains much of what the rest of the world finds baffling about US healthcare.

Genentech demonstrates how pharma brands can reach younger patient communities with esports

Article • Stephen Whiteside, Event Reports, SXSW, March 2021

Genentech, the pharma company, successfully used esports to connect with teenagers and young adults in the US with hemophilia, a rare disorder that reduces the ability of blood to clot.

Over half of adults feel comfortable buying medications online

Data • Rob Clapp, WARC Data Points, March 2021

An overview of consumer interest in buying prescription medication online across 17 markets.

How pharmaceutical brand teams can design new pathways to market and compete on better health outcomes

Article • John G. Singer, WARC Exclusive, December 2020

This article looks at why the pandemic should prompt the pharmaceutical industry to look at strategies beyond drug promotion and look, instead, at partnerships that ultimately provide better health outcomes.

Takeda: Collaborating for change: unlocking the potential of a cutting-edge GI therapy

Research Paper • MRS Awards Papers, Finalist, MRS Award for Healthcare Research, 2020

Takeda, a pharmaceutical company, developed a high-level framework for its communications campaign about a new gastrointestinal therapy.

Towards deeper consumer understanding – Building personas for GSK

Research Paper • MRS Awards Papers, Finalist, MRS Award for New Consumer Insights, 2020

GSK, a British pharmaceutical company, bridged the gap between brand teams, agency teams and creative executions by creating consumer mindset personas that added a new perspective and changed the way people thought about engaging consumers.

Amgen: Big O - Speaking out against a silent disease. A strategy that convinced women osteoporosis is as serious as the Big C

Case Study • Effies (Australia), Australian Effies, Bronze, 2020

Amgen, a world-leading biotechnology company, created its first-ever large-scale, integrated, disease education campaign in Australia by launching The Big O, a multi-faceted osteoporosis awareness campaign.

How ads and pricing shape results for DTC pharma brands

News • 24 September 2020

Advertising is particularly effective in pharma categories where pricing is shaped by a “leader” and a “follower” brand dynamic, according to a study in the Journal of Advertising Research (JAR).

The relationship between competitive pricing and direct-to-consumer advertising: How to manage DTC advertising of Rx drugs in an integrated marketing mix strategy

Research Paper • Abhik Roy and Mary E. Schramm, Journal of Advertising Research, Vol. 60, No. 3, 2020, pp. 305-323

The oligopolistic nature of the U.S. pharmaceutical industry presents its members with a unique opportunity to leverage the interaction between competitive pricing strategy and promotion strategy.

How Viagra Connect’s new campaign is breaking masculinity’s ‘last great taboo’

Article • Chiara Manco, WARC Exclusive, August 2020

Viagra Connect, the first over-the-counter treatment for erectile dysfunction, launched a campaign in the UK to tackle the shame and stigma associated with the condition.

Go digital or go home: Adapting interaction and engagement models with healthcare professionals for post-COVID times

Article • Sameer Desai and Ashish Mahajan, WARC Best Practice, May 2020

With lockdown measures, social distancing and strain on existing healthcare systems thanks to COVID-19, life sciences companies need a whole new model for reaching key stakeholders.

US, DTC prescription products Ad/Sales ratio

Data • Cinzia Petio, WARC Data Points, May 2020

An overview of advertising as a percentage of sales in the DTC prescription products sector in the United States since 2007.

Entyvio: Hyper-Focus on the Patient Journey

Case Study • ARF Ogilvy Awards (US), Silver, 2019

Takeda Pharmaceuticals, a pharmaceutical company, increased registrations for its Entyvio Connect program in the US by creating new datasets to inform a programmatic display and video outreach.

CHANTIX: Ray Liotta Celebrity Testimonial

Case Study • ARF Ogilvy Awards (US), Gold, 2019

CHANTIX®, a medication brand to help smokers quit, used celebrity success story Ray Liotta as a champion for its video campaign to help encourage people in the US to stop smoking.

Pneumovax®/Merck: Chronic Fighter

Case Study • ARF Ogilvy Awards (US), Bronze, 2019

Pneumovax®23/Merck, a vaccine to protect against pneumococcal disease, increased awareness of Pneumococcal Disease (PD) by launching a branded video and delivering messages to healthcare providers in the US.

Novartis: Keep It Pumping

Case Study • SABRE Awards, Asia-Pacific, Public Education, Gold, 2019

Novartis, a pharmaceutical brand, increased awareness of Heart Failure in India by launching Keep It Pumping India, a 360-degree integrated campaign.

Rapid impact: Creating a market leader in a year through machine-learning, ethnography and psychology

Research Paper • Genevieve Hall, Vivek Banerji, Alessandro D’Angelo, Dan Atkins and Daniel Rayner, ESOMAR Conference papers, Congress, 2019

Papilocare, a brand of HPV prevention cream, became the market leader in Italy in just one year thanks to a strategy which was underpinned by hidden and differentiating insights.

Media in-housing tips from Bayer

News • 11 August 2019

Bayer, the pharma company, is in the process of in-housing its digital media buying, and thus has useful tips for other marketers that are thinking about pursuing this approach.

Bayer’s in-house programmatic benefits: 10x the reach and $10 million in savings

Article • Stephen Whiteside, Event Reports, IAB NextGen Marketing Summit, June 2019

Bayer, the pharmaceutical company, is bringing programmatic advertising in-house through a two-year program that scales back agency involvement in this discipline over time.

How to build trust in a stigmatised category

News • 26 June 2019

Epidiolex, a drug developed by GW Pharma, has been shown to be effective in treating rare and complex variants of epilepsy using CBD, but the company has had to build trust in a substance that continues to face preconceptions and the stigma surroundi

Using technology to drive behavioural change in healthcare

Article • D'Arcy King, WARC Best Practice, February 2018

Looks at how new technologies are affecting the healthcare profession and suggests ways that health data can be used to change consumer behaviour.
COVID-19: Consumer spending and media habits in the UK

Data • Marte Aune, Rob Clapp, WARC Data, May 2020

This report analyses consumer spending and media habits in the UK during the novel coronavirus (COVID-19) outbreak, with insights segmented by age, gender and income.
Digital strategy in healthcare marketing: Admap summary deck

Article • Admap Magazine, January 2020

A summary of new thinking and best practice on digital strategy in healthcare marketing from Admap.
Wellness redefined: Fostering wellbeing through digitalisation and technology

Article • Euromonitor Strategy Briefings, February 2021

Examines the intrinsic link between digitalisation and technology and the evolution of wellness.
Go digital or go home: Adapting interaction and engagement models with healthcare professionals for post-COVID times

Article • Sameer Desai and Ashish Mahajan, WARC Best Practice, May 2020

With lockdown measures, social distancing and strain on existing healthcare systems thanks to COVID-19, life sciences companies need a whole new model for reaching key stakeholders.
Where consumers shop for consumer health

Article • Euromonitor Strategy Briefings, January 2021

An industry snapshot of consumer health, including the impact of Coronavirus, channel shifts and future development.